Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,926,733,750
-$104,546,064 QoQ
Shares Held
10,161,026
-1.3% QoQ
Ownership
0.655%
of shares outstanding
% of Portfolio
3.55%
of 13F equity value
Holder Rank
#24
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ROYAL LONDON ASSET MANAGEMENT LTD holds $4,029,879,846 across 10 Drug Manufacturers - General names. AZN ranks #1 (47.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
This page
|
10,161,026 | $1,926,733,750 | |
| 2 | LLY |
ELI LILLY & Co
|
645,864 | $774,668,722 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,987,037 | $383,834,254 | |
| 4 | ABBV |
AbbVie Inc.
|
1,342,483 | $337,822,422 | |
| 5 | JNJ |
Johnson & Johnson
|
1,189,474 | $302,090,711 | |
| 6 | AMGN |
Amgen Inc
|
280,510 | $101,578,281 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
551,867 | $69,722,876 | |
| 8 | PFE |
Pfizer Inc
|
2,819,076 | $67,883,350 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,926,733,750 | 10,161,026 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,031,279,814 | 10,299,563 | Shares | Sole | 2026-05-01 | |
| No filing history on record for this holder in this stock. | ||||||